CDK2 and cancer: A reduction in the phosphorylation levels of CDK1/2/3 and Rb was observed in sh-DNMT1 cancer cells compared to sh-NC cells (Fig. 6A), confirming the additional inhibition of CDK2-Rb signal transduction.